Toggle navigation
COVID-19
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
ESMO Breast Cancer Annual Congress 2023
2023 ASCO Annual Meeting
2023 Society of Surgical Oncology International Conference on Surgical Cancer Care
24th ASBrS Annual Meeting
AACR Annual Meeting 2023
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
Departments
ASCO Plenary Series
Adolescent and Young Adult Oncology
Announcements
Art of Oncology
ASCO State Affiliates
At Microphone 1
The Big Casino
Book Reviews
Clinical Trials Resource Guide
Direct From ASCO
Diversity in Oncology
Education in Oncology
End-of-Life Oncology
Expert’s Corner
FDA Update
Geriatrics for the Oncologist
Health-Care Policy
Hematology Expert Review
In Memoriam
Inside the Black Box
Integrative Oncology
In the Clinic
In the Literature
In the News
Journal Spotlight
Law and Ethics
Letters to the Editor
Living a Full Life
OCE Insights
Oncology Worldwide
Perspectives
Palliative Care in Oncology
Patient’s Corner
Pioneers in Oncology
Prevention in Oncology
Profiles
Psychosocial Oncology
Special Reports
Through the Lens of Oncology History
Women in Oncology
Advertisement
Advertisement
Jun
03
Today In Oncology
Adding Ribociclib to Endocrine Therapy May Reduce Recurrence Risk in Patients With HR-Positive, HER2-Negative Early-Stage Breast Cancer
Simple Hysterectomy May Be a Safe Option for Patients With Early-Stage, Low-Risk Cervical Cancer
Extended Lymphadenectomy May Not Benefit Patients With Clinically Localized Muscle-Invasive Bladder Cancer
Study Finds Wide Variations in Intratumoral Microbiome of Patients With Early- vs Late-Onset Colorectal Cancer
ATOM Coalition Seeks to Ensure Equitable Cancer Care in Low- and Middle-Income Countries
View More
Advertisement